Board Meeting-Closure of Trading Window
Closure of Trading Window for the audited financial results for the quarter and year ended 31.03.201811-05-2018
11-05-2018
Intimation Of Board Meeting To Be Held On 30.05.2018
Intimation of board meeting to be held on 30.05.201811-05-2018
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201527-04-2018
Compliance Certificate For The Period 01.10.2017 To 31.03.2018
compliance certificate for the period 01.10.2017 to 31.03.201827-04-2018
Shareholding for the Period Ended March 31, 2018
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here21-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S. Koni ReddyDesignation :- Director17-04-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy21-02-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Extracts of un-audited financial results for the quarter ended 31.12.2017, published.16-02-2018
Un-Audited Financial Results For The Quarter Ended 31.12.2017
Un-audited financial results for the quarter ended 31.12.201714-02-2018